Catalyst Pharmaceuticals Inc CPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/25/22 EST
17.10quote price arrow up+0.13 (+0.77%)
Volume
78
Close
16.97quote price arrow down-0.06 (-0.35%)
Volume
998,244
52 week range
5.24 - 17.76
Loading...
  • Open16.93
  • Day High17.10
  • Day Low16.47
  • Prev Close17.03
  • 52 Week High17.76
  • 52 Week High Date11/23/22
  • 52 Week Low5.24
  • 52 Week Low Date01/28/22

Key Stats

  • Market Cap1.766B
  • Shares Out104.07M
  • 10 Day Average Volume3.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change150.66

KEY STATS

  • Open16.93
  • Day High17.10
  • Day Low16.47
  • Prev Close17.03
  • 52 Week High17.76
  • 52 Week High Date11/23/22
  • 52 Week Low5.24
  • 52 Week Low Date01/28/22
  • Market Cap1.766B
  • Shares Out104.07M
  • 10 Day Average Volume3.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change150.66

RATIOS/PROFITABILITY

  • EPS (TTM)0.61
  • P/E (TTM)27.91
  • Fwd P/E (NTM)20.90
  • EBITDA (TTM)84.436M
  • ROE (TTM)28.55%
  • Revenue (TTM)191.755M
  • Gross Margin (TTM)84.07%
  • Net Margin (TTM)34.90%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/14/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalyst Pharmaceuticals Inc

 

Profile

MORE
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With the patient focus, the Company is engaged in developing a robust pipeline of cutting-edge, medicines for rare diseases. The Company's New Drug Application for FIRDAPSE (amifampridine) tablets 10 milligrams (mg) for the treatment of adults with Lambert-Eaton...
Patrick McEnany
Chairman of the Board, President, Chief Executive Officer
Steven Miller Ph.D.
Chief Operating Officer, Chief Scientific Officer
Alicia Grande CPA
Chief Financial Officer, Vice President, Treasurer
Address
355 ALHAMBRA CIRCLE, SUITE 801
Coral Gables, FL
33134
United States

Top Peers

SYMBOLLASTCHG%CHG
TWST
Twist Bioscience Corp
25.44-0.09-0.35%
LGND
Ligand Pharmaceuticals Inc
73.61+0.47+0.64%
FGEN
FibroGen Inc
13.85-0.13-0.93%
XNCR
Xencor Inc
28.54+0.05+0.18%
SNDX
Syndax Pharmaceuticals Inc
21.90+0.20+0.92%